Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of all deaths in the U.S., the most recent available data showing it was the primary cause of death for >76,000 women and >68,000 men 45 and over in 2013 (CDC Wonder accessed on September 24, 2015).
Research Meeting Summaries
Filter Research Meeting Summaries
The National Heart, Lung, and Blood Institute (NHLBI) convened a working group meeting consisting of experts in multi-level intervention research on September 15 and 16, 2015. The purpose of the meeting was to provide recommendations that would be useful for designing and implementing multi-level interventions that target hard-to-reach, high risk or vulnerable populations and communities.
Sarcoidosis is an enigmatic disease characterized pathologically by granulomatous inflammation in the lung, heart, brain, eyes, skin, liver and other organs. It remains unclear why patients’ disease manifestations, severity and long-term prognoses vary so widely among the individuals affected.
On June 29-30, 2015, the NHLBI, with co-funding from the NIH Office of Disease Prevention, sponsored a workshop in Bethesda, Maryland, on Cardiovascular and Pulmonary Disease and the Emergence of e-cigarettes. The goal of the meeting was to identify specific gaps in existing research evidence that, if closed, would clarify the acute and chronic pulmonary and cardiovascular health effects of e-cigarette use.
At a joint NHLBI and FDA workshop in May 2015, participants proposed research and policy priorities to address the risk of thrombosis in patients with ventricular assist devices.
On March 25-26, 2015, the NHLBI sponsored a meeting on the state of the science in transfusion medicine on the NIH campus in Bethesda. The goal of this meeting was to identify important research questions that could be answered in the next 5-10 years and that have the potential to transform the clinical practice of transfusion medicine.
In January 2015, a working group recommended steps that can be taken to create a network of data about congenital heart defects.
In September 2014, a working group heard presentations on scientific evidence that sex is a major determinant for the development and progression of cardiovascular disease. Afterward, the group recommended actions that can be taken to promote more research into the impact of sex on cardiovascular health.
In August 2014, a working group identified research needs in the area of cancer-related thrombosis.
The Division of Lung Diseases of the NHLBI convened a workshop on September 25-26, 2014, to identify needed research to advance the targeted delivery of drugs and imaging probes for preventing and treating lung diseases.